EZH2 and breast cancer: Interestingly, targeted expression of wild-type EZH2 (EZH2WT) alone in mammary glands leads to hyperplasia without developing tumors in animal studies12,13, whereas transgenic mice harboring mammary gland-specific expression of constitutively active CDK2 develop mammary tumors containing basal-like components14.